StockData
Rallybio Corp logo

Rallybio Corp (RLYB) stock

RLYBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 10/30
$15.29−0.14 (-0.88%)

Close on Nov 17, 2026Market cap $82.32MP/E 3.4Yield –

How the market prices Rallybio

Each ratio against its own distribution since 2021, from month-end prices and the figures reported at the time

Rallybio trades at 0.9× its earnings, against a median of 0.9× since 2021 — close to the middle of its own range.

The shaded bar covers the 5th to 95th percentile of month-end values since 2021, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to book since 2021

Median 0.9×, today 0.9×

What Rallybio keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Operating margin-5580.9%vs -42.9%
EBITDA margin-5579.0%vs -29.3%
Pretax margin6299.5%vs -13.0%
Net margin6177.4%vs -39.9%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity34.5%vs -53.5%
Return on assets32.8%vs -40.7%
Return on invested capital-718.0%vs -32.4%
Return on capital employed-26.2%vs -38.7%

How hard the assets work

Revenue per dollar of assets0.01vs 0.39
Revenue per employee$31.00Kvs $405.05K
Profit per employee$1.92Mvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $90.70M.

Cash and short-term investments$90.70M
EBITDA, trailing twelve months-$24.21M

Leverage and liquidity

Current ratio28.87vs 3.28
Quick ratio27.63vs 2.37

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

11.42
DistressSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

4 of 9 tests passed

Price against two rules of thumb

Graham's number and Lynch's fair value, both derived from current earnings.

Price $15.29Graham $41.94

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield32.6%vs -22.8%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

$3.6752-week low52-week high$17.57
200-day$15.2920-day50-day

The close sits 84% of the way up the 52-week range, 13.0% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

34
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

RLYBS&P 500
PeriodRLYBS&P 500DifferenceRLYB per yearS&P 500 per year
1 month-6.1%-4.0%−2.0 pts
3 months-10.1%-5.0%−5.1 pts
Year to date+178.6%+8.2%+170.3 pts
1 year+209.7%+11.2%+198.5 pts
3 years-4.0%+68.5%−72.4 pts-1.3%+19.0%
5 years-85.5%+67.3%−152.8 pts-32.0%+10.8%

How much it moves

Volatility, 1 year84.0%vs 80.5%
Volume against its 90-day average1.83vs 0.86

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M RLYB shares were sold short on Oct 30, 2026, down 4.7% from the previous report, or 2.65% of the shares available to trade. At recent volumes it would take 1.2 days to buy them back. Over the last 20 sessions, 43.9% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float2.65%vs 8.89%
Short interest as a share of all shares0.72%vs 6.30%
Days of volume to buy it back1.18vs 5.13

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202639,026-4.7%33,1711.2
Oct 15, 202640,962-16.8%5,5447.4
Sep 30, 202649,245-11.4%10,0954.9
Sep 15, 202655,556+1.1%11,0225.0
Aug 31, 202654,943+0.7%9,9965.5
Aug 14, 202654,564-14.1%26,9812.0
Jul 31, 202663,485-62.7%30,8442.1
Jul 15, 2026170,156-58.4%48,1243.5
Jun 30, 2026408,746-3.8%47,5728.6
Jun 15, 2026425,033-27.6%86,4544.9
May 29, 2026586,906+1.4%48,97712.0
May 15, 2026578,792-63.2%1,001,4111.0

Every measure, in full

72 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
Nov 23, 2026
Fundamentals through
Sep 30, 2026
Share price as of
Nov 17, 2026

Valuation ratiosIndustry

Market Cap
$82.32M
$254.69M
Enterprise Value
-$8.38M
$130.88M
PE Ratio
3.35
23.02
PS Ratio
189.68
3.66
PB Ratio
0.89
1.99
P/TBV Ratio
0.89
2.23
P/OCF Ratio
2.66
13.24

Enterprise valuationIndustry

EV / Sales
-19.31
2.38

Share statisticsIndustry

Shares Change (YoY)
2.07%
11.0%
Shares Change (QoQ)
0.50%
0.57%
Float
1M
49M
Shares Held by Insiders
72.6%
11.3%

Short sellingIndustry

Short Interest
39,026
–
Short Interest Change
-4.73%
-0.80%
Short % of Float
2.65%
8.89%
Short % of Shares Outstanding
0.72%
6.30%
Days to Cover
1.18
5.13

Stock price statisticsIndustry

52-Week High
$17.57
–
52-Week Low
$3.67
–
20-Day Moving Average
$15.85
–
50-Day Moving Average
$16.46
–
200-Day Moving Average
$13.56
–
Average True Range (14)
$0.51
–
Price Change (1 Week)
-2.98%
-7.83%
Price Change (1 Month)
-6.48%
-6.48%
Price Change (3 Months)
-10.1%
-26.6%
Price Change (6 Months)
7.75%
-22.2%
Price Change (YTD)
178.6%
-25.6%
Price Change (1 Year)
198.5%
-23.8%
Price Change (3 Years)
-3.96%
-32.9%
Price Change (5 Years)
-85.1%
-77.3%
Average Volume (10 Days)
37,234
–
Average Volume (20 Days)
34,902
–
Average Volume (90 Days)
23,171
–
Relative Volume
1.83
0.86
Relative Strength Index (14)
33.9
40.3
Volatility (1 Year)
84.0%
80.5%

MarginsIndustry

Operating Margin
-5580.9%
-42.9%
Pretax Margin
6299.5%
-13.0%
Profit Margin
6177.4%
-39.9%
EBITDA Margin
-5579.0%
-29.3%

Returns on capitalIndustry

Return on Equity (ROE)
34.5%
-53.5%
Return on Assets (ROA)
32.8%
-40.7%
Return on Invested Capital (ROIC)
-718.0%
-32.4%
Return on Capital Employed (ROCE)
-26.2%
-38.7%

Financial positionIndustry

Current Ratio
28.87
3.28
Quick Ratio
27.63
2.37

GrowthIndustry

Revenue Growth (YoY)
-35.6%
5.68%

EfficiencyIndustry

Asset Turnover
0.01
0.39
Revenue Per Employee
$31.00K
$405.05K
Profits Per Employee
$1.92M
-$704.12K
Employee Count
14
75

Income statement (TTM)Industry

Revenue
$434.00K
$58.79M
Operating Income
-$24.22M
-$21.49M
Pretax Income
$27.34M
-$14.83M
Net Income
$26.81M
-$22.47M
EBITDA
-$24.21M
-$17.14M
EPS (Diluted)
$4.56
-$0.83

Balance sheetIndustry

Net Cash (Debt)
$90.70M
$15.31M
Net Cash Per Share
$16.85
$0.72
Equity (Book Value)
$92.30M
$49.40M
Book Value Per Share
$17.14
$1.45
Tangible Book Value
$92.30M
$23.58M
Working Capital
$91.49M
$74.34M

Cash flow (TTM)Industry

Operating Cash Flow
$30.99M
-$12.17M

Dividends and yieldsIndustry

Earnings Yield
32.6%
-22.8%

Scores and fair valueIndustry

Graham Number
$41.94
$19.07
Graham Upside
174.3%
-47.6%
Altman Z-Score
11.42
0.12
Piotroski F-Score
4
4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?